Please login to the form below

Not currently logged in
Email:
Password:

Cipla invests £100m in UK

Indian pharma company to fund both commercial and R&D activities
UK flag

India-based pharma company Cipla has made inroads into the UK with a £100m investment in both research and commercial areas.

Cipla, which is best known for its pioneering role in providing HIV treatment to developing nations, intends to launch a range of drugs in respiratory, oncology and antiretroviral indications.

The company will also put money towards R&D, clinical trials and further expansion in the UK in what is a sign of confidence in the country's ability to attract pharma investment following downsizing by the likes of Pfizer and Novartis.

UK Chancellor of the Exchequer George Osborne said: “Cipla is one of India's leading pharmaceutical firms and this decision shows the UK's international strength and attractiveness in this sector as well as its growing importance in Cipla's long term strategy.”

Cipla's chief financial officer Rajesh Garg explained that the company was attracted by the strength of the UK's NHS and by recent government efforts to improve the research environment, including the Life Sciences Strategy.

“We are very pleased to be making this investment in the UK,” said Garg. “We were impressed with the pro-active support and engagement that the UK Government and its various ministries showed in attracting Cipla to choose the UK as a key hub in our global footprint.”

11th July 2014

From: Research, Sales, Healthcare

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics